scholarly journals Toward a Coronavirus Knowledge Graph

Genes ◽  
2021 ◽  
Vol 12 (7) ◽  
pp. 998
Author(s):  
Peng Zhang ◽  
Yi Bu ◽  
Peng Jiang ◽  
Xiaowen Shi ◽  
Bing Lun ◽  
...  

This study builds a coronavirus knowledge graph (KG) by merging two information sources. The first source is Analytical Graph (AG), which integrates more than 20 different public datasets related to drug discovery. The second source is CORD-19, a collection of published scientific articles related to COVID-19. We combined both chemo genomic entities in AG with entities extracted from CORD-19 to expand knowledge in the COVID-19 domain. Before populating KG with those entities, we perform entity disambiguation on CORD-19 collections using Wikidata. Our newly built KG contains at least 21,700 genes, 2500 diseases, 94,000 phenotypes, and other biological entities (e.g., compound, species, and cell lines). We define 27 relationship types and use them to label each edge in our KG. This research presents two cases to evaluate the KG’s usability: analyzing a subgraph (ego-centered network) from the angiotensin-converting enzyme (ACE) and revealing paths between biological entities (hydroxychloroquine and IL-6 receptor; chloroquine and STAT1). The ego-centered network captured information related to COVID-19. We also found significant COVID-19-related information in top-ranked paths with a depth of three based on our path evaluation.

2020 ◽  
pp. 1-6
Author(s):  
Eugene H. Cordes

The opportunity to see the fruit of scientific work in one’s own lifetime proved a compelling motivation to leave a productive academic career in biochemistry and join the pharmaceutical industry, the Merck Research Laboratories specifically. Beginning with work on benign prostatic hypertrophy, the work became involved with statins, angiotensin-converting enzyme inhibitors, and other areas of drug discovery. Taken from experiences at Merck and elsewhere, eleven adventure stories in drug discovery are presented, ten successes and one notable failure. It is emphasized that most of what scientists start in drug discovery eventually fails, but that pharmaceutical scientists are nonetheless enthusiastic about prospects for success in their work and dedicated to it. The organization of this book is provided.


Sign in / Sign up

Export Citation Format

Share Document